SNO Grand Rounds: IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial Recording

The Neuro-Oncology Academy is pleased to announce the first CME webinar in the SNO Grand Rounds Series, IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial, an activity provided by the Society for Neuro-Oncology.
 

This recorded course is not for credit.

 

Registration

Click here to be directed to the Neuro-Oncology Academy to register. The webinar is free for all; please use your SNO username and login to register. If you are having trouble logging in, please contact caroline@soc-neuro-ong.org.

 

Physician Credit Designation

This recording is not for credit.

 

About the Academy and the SNO Grand Rounds Series

The Neuro-Oncology Academy is education brought to you by the Society for Neuro-Oncology. Its mission is to provide quality education in a variety of engaging formats for multi-disciplinary professionals in the field of neuro-oncology. The SNO Grand Rounds Series seeks to address a range of timely and important new findings in the field of neuro-oncology.

 The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Target Audience

Neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, neuro-pathologists, physicians/scientists, clinical and laboratory trainees, and allied health professionals.

Learning Objectives

After participating in this CME activity, participants should be able to: 

  • Describe the clinical trial design and objectives of the INDIGO study .
  • Review INDIGO study results including outcomes and toxicity data.
  • Interpret the latest clinical trial study results regarding IDH-mutant gliomas.
Course summary
Course opens: 
07/26/2023
Course expires: 
10/23/2028
Cost:
$0.00

INDIGO Trial 
Patrick Wen, MD, Dana-Farber Cancer Institute

INDIGO: A Closer Look at the Data 
Martin Van Den Bent, MD, Erasmus MC-Daniel den Hoed Cancer Center

The INDIGO Trial Results: Impact on Clinical Care and Future Directions 
Susan Chang, MD, University of California, San Francisco

Speakers
Patrick Wen, MD, Dana-Farber Cancer Institute
Martin Van Den Bent, MD, Erasmus MC-Daniel den Hoed Cancer Center
Susan Chang, MD, University of California, San Francisco


Moderators
Julie Miller, MD, PhD, Mass General 
Katherine Peters, MD, PhD, Duke University


Neuro-Oncology Academy Leadership
Isabel Arrillaga-Romany, MD, PhD, Scientific Director
Eric Sulman, MD, PhD, Co-Director, Basic and Translational Science
Farshad Nassiri, MD, PhD, Co-Director, SNO Track Leader
Shawn Hervey-Jumper, MD, PhD, Co-Director, Annual Meeting Liaison
Sonia Partap, MD, Co-Director, Pediatric Research
Manish Agi, MD, PhD, Co-Director, Clinical Research
Tracy Batchelor, MD, Ex-Offico
Chas Haynes, JD, Ex-Offico

The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Price

Cost:
$0.00
Please login or register to take this course.

Registration Instructions:

Please fill out the webform at the time of enrollment. *See step 2 in the instructions.

Instructions on How to Watch the Module:

  1. Click the Take Course Button
  2. On the course progress bar, click the webform.
  3. Click the blue start button to fill out the webform.
  4. Complete the webform, then click submit.
  5. Then Click next to proceed to the video

If you have any technical difficulties or have any questions, please reach out to academy@soc-neuro-onc.org.